Commercial dexamethasone degradation by heterogeneous sono/photo-Fenton process using iron zeolite catalyst by an electrodeposition method
Dexamethasone (DXM) was the first drug used to treat COVID-19, only a small part is metabolized and has been identified in wastewater and surface water, conventional treatments do not remove these compounds, therefore new technologies must be developed. A commercially injectable solution containing...
Description complète
Détails bibliographiques
| Publié dans: | Environmental technology. - 1993. - 46(2025), 13 vom: 15. Mai, Seite 2376-2393
|
|---|
| Auteur principal: |
Castañeda-Juárez, Monserrat
(Auteur) |
|---|
| Autres auteurs: |
Linares-Hernández, Ivonne,
Martínez-Miranda, Verónica,
Teutli-Sequeira, Elia Alejandra,
de Los Ángeles Mier-Quiroga, Miroslava,
Castillo-Suárez, Luis Antonio |
|---|
| Format: | Article en ligne
|
|---|
| Langue: | English |
|---|
| Publié: |
2025
|
|---|
| Accès à la collection: | Environmental technology
|
|---|
| Sujets: | Journal Article
Advanced oxidation process
COVID-19 pharmaceuticals
electrosynthesis
oxidation
sonochemical technologies
Dexamethasone
7S5I7G3JQL
Zeolites
1318-02-1
plus...
Hydrogen Peroxide
BBX060AN9V
Iron
E1UOL152H7
Water Pollutants, Chemical
Fenton's reagent |
|---|